共 50 条
- [32] Does pegylated interferon α-2b confer additional benefit in the adjuvant treatment of high-risk melanoma? [J]. NATURE CLINICAL PRACTICE ONCOLOGY, 2009, 6 (02): : 70 - 71
- [33] Does pegylated interferon α-2b confer additional benefit in the adjuvant treatment of high-risk melanoma? [J]. Nature Clinical Practice Oncology, 2009, 6 : 70 - 71
- [34] Adjuvant therapy with high-dose interferon α2b in patients with high-risk stage IIB/III melanoma [J]. NATURE CLINICAL PRACTICE ONCOLOGY, 2008, 5 (01): : 2 - 3
- [36] Adjuvant therapy with high-dose interferon α2b in patients with high-risk stage IIB/III melanoma [J]. Nature Clinical Practice Oncology, 2008, 5 : 2 - 3
- [40] Pegylated Interferon α-2b, Ribavirin and Amantadine for Chronic Hepatitis C [J]. Digestive Diseases and Sciences, 2005, 50 : 970 - 975